-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Underweight on XPLR Infr, Raises Price Target to $12

Benzinga·02/12/2026 15:19:37
Listen to the news
Barclays analyst Betty Jing maintains XPLR Infr (NYSE:XIFR) with a Underweight and raises the price target from $10 to $12.